Bora Pharmaceuticals Co., Ltd. (TPE:6472)
Taiwan · Delayed Price · Currency is TWD 379.00
-13.00 (-3.32%)
Oct 30, 2026, 1:30 PM CST
Bora Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Bora Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $578.90. The average 1-year stock price forecast is 52.74% higher than the current stock price, while the lowest is $480.00 (+26.65%) and the highest is $729.29 (+92.42%).
Price Target: $578.90 (+52.74%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Bora Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 3 | 3 | 3 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 2 | 1 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 6 | 6 | 7 | 7 | 7 |
Financial Forecast
Revenue This Year
23.11B
from 19.01B
Increased by 21.56%
Revenue Next Year
29.02B
from 23.11B
Increased by 25.54%
EPS This Year
17.52
from 23.24
Decreased by -24.61%
EPS Next Year
31.93
from 17.52
Increased by 82.25%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is TWD.